Efficacy of bodyγ-knife with radiosensitizer and/or hyperthermia for recurrent soft tis-sue sarcoma
10.3969/j.issn.1000-8179.2017.01.075
- VernacularTitle:立体定向放疗配合热疗及增敏剂治疗复发软组织肉瘤疗效观察
- Author:
Jingbo KANG
;
Yufei ZHANG
;
Qi ZHU
;
Qiliang LI
- Keywords:
bodyγ-knife;
soft tissue sarcoma;
hyperthermia;
radiosensitizer
- From:
Chinese Journal of Clinical Oncology
2017;44(1):24-28
- CountryChina
- Language:Chinese
-
Abstract:
Objective:This study investigates the clinical effect of bodyγ-knife combined with radiosensitizer and/or hyperthermia. for the recurrence of soft tissue sarcoma. Methods:Sixty-three patients with recurrent soft tissue sarcoma from January 2012 to March 2014 were treated by bodyγ-knife combined with radiosensitizer and/or hyperthermia. The patients were exposed to radiation dose levels of 4-5.5 Gy/fraction (10-13 fractions) with total doses of 44-55 Gy and 55%-70%isodose, including 95%PTV. The radiosensitizer, sodium glycodidazolum (CMNa), was administered to all patients at 1.00-1.50 g V.D qod at 5-6 fractions 0-3 h before bodyγ-knife treat-ment. Hyperthermia for 30 patients was delivered during the bodyγ-knife treatment with two fractions/week for a total of six frac-tions. Results:The total response rate was 77.7%three months after the treatment. The one and two year local control rates were 78.8%and 63.6%, respectively, while the survival rates of patients treated with bodyγ-knife with radiosensitizer at one and two years were 75.7%and 63.6%, respectively. The local control rates at one and two years were 83.6%and 70.0%, respectively, while the surviv-al rates at one and two years for bodyγ-knife combined with radiosensitizer and hyperthermia treatments were 80.0%and 63.3%, re-spectively. Serious complications of radiotherapy were not observed. Conclusion:Bodyγ-knife combined with radiosensitizer and/or hyperthermia is effective for recurrent soft tissue sarcoma.
